Mehanna, Hisham ;
Robinson, Max ;
Hartley, Andrew...
Mehanna , H , Robinson , M , Hartley , A , Kong , A , Foran , B , Fulton-Lieuw , T , Dalby , M , Mistry , P , Sen , M , O'Toole , L , Al Booz , H , Dyker , K , Moleron , R , Whitaker , S , Brennan , S , Cook , A , Griffin , M , Aynsley , E , Rolles , M , de Winton , E , Chan , A , Srinivasan , D , Nixon , I , Grumett , J , Leemans , C R , Buter , J , Henderson , J , Harrington , K , McConkey , C , Gray , A , Dunn , J , Moleron , R , McArdle , O , Dyker , K , Al Booz , H , O'Toole , L , Cook , A , Husband , D , Loo , V , Soe , W , Aynsley , E , Sridhar , T , Jankowska , P , Joseph , M , Geropantas , K , Vaidya , D , Griffin , M , Hartley , A , Vijayan , R , Buter , J & De-ESCALaTE HPV Trial Group 2019 , ' Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial ' , Lancet , vol. 393 , no. 10166 , pp. 51-60 . https://doi.org/10.1016/S0140-6736(18)32752-1.
,
2019
